Global Patent Index - EP 1086127 A1

EP 1086127 A1 2001-03-28 - NOVEL COMPOUNDS

Title (en)

NOVEL COMPOUNDS

Title (de)

NEUE ZUSAMMENSETZUNGEN

Title (fr)

NOUVEAUX COMPOSES

Publication

EP 1086127 A1 (EN)

Application

EP 99950345 A

Priority

  • EP 9903262 W
  • GB 9810193 A

Abstract (en)

[origin: WO9958562A2] The invention provides BASB009 polypeptides and polynucleotides encoding BASB009 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.

IPC 1-7 (main, further and additional classification)

C07K 14/21; A61K 39/02; C07K 16/12; C12N 15/31; C12N 15/62; C12N 15/63

IPC 8 full level (invention and additional information)

C07K 14/21 (2006.01); C12N 15/31 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

C07K 14/212 (2013.01); A61K 39/00 (2013.01)

Citation (search report)

See references of WO 9958562A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9958562 A2 19991118; WO 9958562 A3 20010517; AU 4260199 A 19991129; CA 2328061 A1 19991118; EP 1086127 A1 20010328; GB 9810193 D0 19980708

INPADOC legal status


2004-06-09 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20031122

2003-08-27 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030711

2003-01-15 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: GLAXOSMITHKLINE BIOLOGICALS S.A.

2001-03-28 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001212

2001-03-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

2001-03-28 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO

- Free text: SI PAYMENT 20001212